Karan Mohan, MD
Hospitalist · St. Joseph, MONPI 1801295258
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,900 of the $6,421 with a category attached, or 60.7%. AbbVie accounts for 69.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $2,540 and has fallen 67.1% since, to $835 in 2024. Among hospitalist clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $142.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Gilead$979
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$442
- Johnson & Johnson$329
- Pfizer$131
- E.r. Squibb & Sons, L.L.C.$35
- plus $20 from 1 others
What the payments were for
- Consulting fees$71011%
- Speaking & faculty fees$3,90061%
- Travel & lodging$711%
- Food & beverage$1,74027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $4,486 |
| Gilead | 5 | $979 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $442 |
| Johnson & Johnson | 10 | $329 |
| Pfizer | 7 | $131 |
| E.r. Squibb & Sons, L.L.C. | 3 | $35 |
| Novartis | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,421 in reported general payments places this provider in the 95th percentile of 712 hospitalist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $107 |
| Oxycodone Hcl | 11 | $72 |
| Levofloxacin | 19 | $68 |
| Prednisone | 21 | $51 |
| Lisinopril | 15 | $28 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in St. Joseph
- Mir ZulqarnainKansas City$161K
- Gian MusarraSaint Louis$25K
- Ghassan DaherSaint Louis$23K
- Marsha SchulteSaint Louis$23K
- Ijeoma NwelueSaint Louis$12K
- Aniesh BobbaColumbia$6K
- Arun MannemSaint Louis$6K
- Vasanthan KuppuswamySaint Louis$5K
- Yamuna KondapallySaint Louis$5K
- Rita MukerjiFlorissant$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.